Clinical Trial Update: Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharmacogenetic factors that influence response to GLP-1 therapies in Mexican-Americans with prediabetes. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: PreDiabetes | Phase 4 | Status: RECRUITING